Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus...
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer
About this item
Full title
Author / Creator
Bines, José , Clark, Emma , Barton, Claire , Restuccia, Eleonora , Procter, Marion , Sonnenblick, Amir , Fumagalli, Debora , Parlier, Damien , Arahmani, Amal , Baselga, José , Viale, Giuseppe , Reaby, Linda L. , Frank, Elizabeth , Gelber, Richard D. , Piccart, Martine , Jackisch, Christian and Petersen, Jennifer A.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
We assessed health-related quality of life (symptoms of therapy/patient functioning/global health status), in APHINITY (pertuzumab/placebo, trastuzumab, and chemotherapy as adjuvant HER2-positive early breast cancer therapy).
Methods
Patients received 1 year/18 cycles of pertuzumab/placebo with trastuzumab and chemotherapy and c...
Alternative Titles
Full title
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8257679
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8257679
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-021-01323-y
